May 09, 2023

Cairnhill CIPEF Limited and Cairnhill CGPE Limited, entities managed by Capital Group, in relation to the IPO of equity shares, by Mankind Pharma Limited

AZB & Partners recently advised Cairnhill CIPEF Limited and Cairnhill CGPE Limited, entities managed by Capital Group, in relation to the initial public offering (“IPO”) of equity shares of face value of INR 1 each (“Equity Shares”), by Mankind Pharma Limited (“Company”), which was undertaken by way of an offer for sale of Equity Shares by the selling shareholders, which aggregated to INR 43.26 billion. This deal is one of the largest public offerings by a domestic drug manufacturer in India since 2020.

The team advising the entities managed by Capital Group, comprised our Senior Partners, Darshika Kothari, Varoon Chandra and Agnik Bhattacharyya; Partner, Prerak Ved; Senior Associates, Rahul Aggarwal, Sneha Nagvekar and Alby Joseph; and Associates, Aratrika Choudhuri and Harsh Vardhan Singh.

AUTHORS & CONTRIBUTORS

TAGS

SHARE

DISCLAIMER

These are the views and opinions of the author(s) and do not necessarily reflect the views of the Firm. This article is intended for general information only and does not constitute legal or other advice and you acknowledge that there is no relationship (implied, legal or fiduciary) between you and the author/AZB. AZB does not claim that the article's content or information is accurate, correct or complete, and disclaims all liability for any loss or damage caused through error or omission.